Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 37 of 1714:
27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47
Gene Compound Assay Inh Ic50 Ki View
adrenergic receptor, alpha 2a LEAD(IV) ACETATE Adrenergic alpha2A 68% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, nonvoltage-gated 1 alpha MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, voltage-gated, type X, alpha MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, voltage-gated, type IX, alpha MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, voltage gated, type VIII, alpha MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, voltage-gated, type VII, alpha MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, voltage-gated, type IV, beta MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, voltage-gated, type IV, alpha MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
histamine receptor H 2 QUINACRINE Histamine H2 72% 3.535uM 3.476uM View
adrenergic receptor, alpha 1d (Non-specific probe) IMIQUIMOD Adrenergic alpha1D 72% 2.621uM 1.288uM View
calcium channel, voltage-dependent, beta 4 subunit BOPINDOLOL Calcium Channel Type L, Benzothiazepine 72% 2.805uM 2.493uM View
calcium channel, voltage-dependent, beta 3 subunit BOPINDOLOL Calcium Channel Type L, Benzothiazepine 72% 2.805uM 2.493uM View
calcium channel, voltage-dependent, beta 2 subunit BOPINDOLOL Calcium Channel Type L, Benzothiazepine 72% 2.805uM 2.493uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit BOPINDOLOL Calcium Channel Type L, Benzothiazepine 72% 2.805uM 2.493uM View
calcium channel, voltage-dependent, alpha 1F subunit BOPINDOLOL Calcium Channel Type L, Benzothiazepine 72% 2.805uM 2.493uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit BOPINDOLOL Calcium Channel Type L, Benzothiazepine 72% 2.805uM 2.493uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit BOPINDOLOL Calcium Channel Type L, Benzothiazepine 72% 2.805uM 2.493uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit BOPINDOLOL Calcium Channel Type L, Benzothiazepine 72% 2.805uM 2.493uM View
calcium channel, voltage-dependent, beta 1 subunit BOPINDOLOL Calcium Channel Type L, Benzothiazepine 72% 2.805uM 2.493uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit BOPINDOLOL Calcium Channel Type L, Benzothiazepine 72% 2.805uM 2.493uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit BOPINDOLOL Calcium Channel Type L, Benzothiazepine 72% 2.805uM 2.493uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 BOPINDOLOL Calcium Channel Type L, Benzothiazepine 72% 2.805uM 2.493uM View
calcium channel, voltage-dependent, gamma subunit 8 BOPINDOLOL Calcium Channel Type L, Benzothiazepine 72% 2.805uM 2.493uM View
calcium channel, voltage-dependent, gamma subunit 7 BOPINDOLOL Calcium Channel Type L, Benzothiazepine 72% 2.805uM 2.493uM View
calcium channel, voltage-dependent, gamma subunit 6 BOPINDOLOL Calcium Channel Type L, Benzothiazepine 72% 2.805uM 2.493uM View
calcium channel, voltage-dependent, gamma subunit 5 BOPINDOLOL Calcium Channel Type L, Benzothiazepine 72% 2.805uM 2.493uM View
calcium channel, voltage-dependent, gamma subunit 4 BOPINDOLOL Calcium Channel Type L, Benzothiazepine 72% 2.805uM 2.493uM View
calcium channel, voltage-dependent, gamma subunit 3 BOPINDOLOL Calcium Channel Type L, Benzothiazepine 72% 2.805uM 2.493uM View
calcium channel, voltage-dependent, gamma subunit 2 BOPINDOLOL Calcium Channel Type L, Benzothiazepine 72% 2.805uM 2.493uM View
calcium channel, voltage-dependent, gamma subunit 1 BOPINDOLOL Calcium Channel Type L, Benzothiazepine 72% 2.805uM 2.493uM View
Cytochrom P450-2C19 monooxygenase NIMODIPINE CYP450-2C19 Inhibition 72% 4uM NoneNone View
dopamine receptor D1A OXICONAZOLE Dopamine D1 72% 4.1361uM 2.068uM View
opioid receptor, delta 1 OXICONAZOLE Opiate delta 72% 5.3081uM 1.8712uM View
5-hydroxytryptamine (serotonin) receptor 2B OXYMETAZOLINE Serotonin 5-HT2B 72% 3.056uM 1.945uM View
ATPase, Na+/K+ transporting, alpha 4 polypeptide SODIUM ORTHOVANADATE ATPase, Na+/K+ 72% 1.853uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 1A PROMAZINE Serotonin 5-HT1A 72% 5.172uM 2.955uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 VX-745 Adrenergic, Norepinephrine Transporter 72% 20.404uM 20.236uM View
opioid receptor, sigma 1 PAROXETINE Sigma1 72% 5.366uM 2.255uM View
tachykinin receptor 2 METERGOLINE Tachykinin NK2 72% 4.071uM 1.357uM View
adrenergic receptor, alpha 1b PERGOLIDE Adrenergic alpha1B 72% 2.622uM 1.452uM View
adrenergic receptor, alpha 2a PRAZOSIN Adrenergic alpha2A 72% 2.638uM .989uM View
adrenergic receptor, alpha 2a METOCLOPRAMIDE Adrenergic alpha2A 72% 2.721uM 1.02uM View
melanocortin 5 receptor ECONAZOLE Melanocortin MC5 72% 39.538uM 37.089uM View
Protein-tyrosine kinase, Fyn EPIRUBICIN Protein Tyrosine Kinase, Fyn 72% 5.181uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 1B KETOCONAZOLE Serotonin 5-HT1B 72% 13.539uM 6.154uM View
adrenergic receptor, alpha 1b DEXCHLORPHENIRAMINE Adrenergic alpha1B 72% 15.56uM 8.613uM View
Sigma-2 Receptor LEVAMISOLE Sigma2 72% 4.392uM 2.703uM View
phosphodiesterase 5A, cGMP-specific LY-294002 Phosphodiesterase PDE5 72% 9.614uM NoneNone View
phosphodiesterase 5A, cGMP-specific LY-294002 Phosphodiesterase PDE5 72% 9.614uM NoneNone View
opioid receptor, kappa 1 DANAZOL Opiate kappa 72% 15.518uM 6.207uM View
A3 adenosine receptor DANAZOL Adenosine A3 72% 11.16uM 6.309uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 ESTRONE Serotonin Transporter 72% 5.301uM 2.816uM View
androgen receptor FLUTAMIDE Testosterone 72% 13.39uM 8.927uM View
5-hydroxytryptamine (serotonin) receptor 2B BETA-ESTRADIOL 3-BENZOATE Serotonin 5-HT2B 72% 11.565uM 7.359uM View
melanocortin 5 receptor CHLORPROMAZINE Melanocortin MC5 72% 7.617uM 7.145uM View
chemokine (C-C motif) receptor 2 AMIODARONE Chemokine CCR2B 72% 11.086uM 4.285uM View
calcium channel, voltage-dependent, gamma subunit 8 LOVASTATIN Calcium Channel Type L, Phenylalkylamine 72% 6.318uM 6.142uM View
calcium channel, voltage-dependent, gamma subunit 7 LOVASTATIN Calcium Channel Type L, Phenylalkylamine 72% 6.318uM 6.142uM View
calcium channel, voltage-dependent, gamma subunit 6 LOVASTATIN Calcium Channel Type L, Phenylalkylamine 72% 6.318uM 6.142uM View
calcium channel, voltage-dependent, gamma subunit 5 LOVASTATIN Calcium Channel Type L, Phenylalkylamine 72% 6.318uM 6.142uM View
calcium channel, voltage-dependent, gamma subunit 6 L-744832 Calcium Channel Type L, Dihydropyridine 70% 4.501uM 2.893uM View
calcium channel, voltage-dependent, gamma subunit 5 L-744832 Calcium Channel Type L, Dihydropyridine 70% 4.501uM 2.893uM View
calcium channel, voltage-dependent, gamma subunit 4 L-744832 Calcium Channel Type L, Dihydropyridine 70% 4.501uM 2.893uM View
calcium channel, voltage-dependent, gamma subunit 3 L-744832 Calcium Channel Type L, Dihydropyridine 70% 4.501uM 2.893uM View
adrenergic receptor, alpha 2b QUINACRINE Adrenergic alpha2C 70% 3.857uM .56uM View
adrenergic receptor, alpha 2c (Non-specific probe) QUINACRINE Adrenergic alpha2C 70% 3.857uM .56uM View
calcium channel, voltage-dependent, gamma subunit 8 QUINACRINE Calcium Channel Type L, Benzothiazepine 70% 1.076uM .956uM View
calcium channel, voltage-dependent, gamma subunit 7 QUINACRINE Calcium Channel Type L, Benzothiazepine 70% 1.076uM .956uM View
calcium channel, voltage-dependent, gamma subunit 6 QUINACRINE Calcium Channel Type L, Benzothiazepine 70% 1.076uM .956uM View
calcium channel, voltage-dependent, gamma subunit 5 QUINACRINE Calcium Channel Type L, Benzothiazepine 70% 1.076uM .956uM View
calcium channel, voltage-dependent, gamma subunit 4 QUINACRINE Calcium Channel Type L, Benzothiazepine 70% 1.076uM .956uM View
calcium channel, voltage-dependent, gamma subunit 3 QUINACRINE Calcium Channel Type L, Benzothiazepine 70% 1.076uM .956uM View
calcium channel, voltage-dependent, gamma subunit 2 QUINACRINE Calcium Channel Type L, Benzothiazepine 70% 1.076uM .956uM View
calcium channel, voltage-dependent, gamma subunit 1 QUINACRINE Calcium Channel Type L, Benzothiazepine 70% 1.076uM .956uM View
calcium channel, voltage-dependent, beta 4 subunit QUINACRINE Calcium Channel Type L, Benzothiazepine 70% 1.076uM .956uM View
adrenergic receptor, alpha 2a DIMENHYDRINATE Adrenergic alpha2A 70% 4.313uM 1.617uM View
5-hydroxytryptamine (serotonin) receptor 1B PIPAMAZINE Serotonin 5-HT1B 70% 3.007uM 1.367uM View
5-hydroxytryptamine (serotonin) receptor 5B EPIRUBICIN Serotonin 5-HT4 70% 7.935uM 1.323uM View
5-hydroxytryptamine (serotonin) receptor 4 EPIRUBICIN Serotonin 5-HT4 70% 7.935uM 1.323uM View
amiloride-sensitive cation channel 5, intestinal KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, voltage-gated, type III, beta KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, voltage-gated, type XI, alpha KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, voltage-gated, type I, beta KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, voltage-gated, type 10, alpha polypeptide KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, voltage-gated, type IV, alpha polypeptide KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, voltage-gated, type V, alpha polypeptide KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, voltage-gated, type II, beta KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, nonvoltage-gated 1 alpha KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, nonvoltage-gated 1 gamma KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, nonvoltage-gated 1 beta KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, voltage-gated, type XI, alpha KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, nonvoltage-gated 1, gamma KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, nonvoltage-gated 1, delta KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, nonvoltage-gated 1 alpha KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, voltage-gated, type X, alpha KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, voltage-gated, type IX, alpha KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, voltage gated, type VIII, alpha KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, voltage-gated, type VII, alpha KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, voltage-gated, type IV, beta KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, voltage-gated, type IV, alpha KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, voltage-gated, type III, alpha KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, voltage-gated, type II, beta KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, voltage-gated, type II, alpha 2 KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, voltage-gated, type I, beta KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, voltage-gated, type I, alpha KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, voltage-gated, type IV, beta KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, voltage-gated, type III, alpha MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, voltage-gated, type II, beta MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, voltage-gated, type II, alpha 2 MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, voltage-gated, type I, beta MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, voltage-gated, type I, alpha MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, voltage-gated, type IV, beta MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel associated protein 1 MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel associated protein 2 MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, voltage-gated, type III, beta MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, voltage-gated, type I, alpha MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, voltage-gated, type IX, alpha MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, voltage-gated, type VII, alpha MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
amiloride-sensitive cation channel 5, intestinal MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, voltage-gated, type III, beta MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, voltage-gated, type XI, alpha MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, voltage-gated, type I, beta MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, voltage-gated, type 10, alpha polypeptide MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, voltage-gated, type IV, alpha polypeptide MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, voltage-gated, type V, alpha polypeptide MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, voltage-gated, type II, beta MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, nonvoltage-gated 1 alpha MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, nonvoltage-gated 1 gamma MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, nonvoltage-gated 1 beta MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, voltage-gated, type XI, alpha MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, nonvoltage-gated 1, gamma MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
sodium channel, nonvoltage-gated 1, delta MEDROXYPROGESTERONE ACETATE Sodium Channel, Site 2 68% 14.954uM 13.407uM View
5-hydroxytryptamine (serotonin) receptor 2C BUSPIRONE Serotonin 5-HT2C 68% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 (S)-(-)-PINDOLOL Dopamine Transporter 68% NoneNone NoneNone View
cannabinoid receptor 1 (brain) NITRENDIPINE Cannabinoid CB1 68% NoneNone NoneNone View
cholinergic receptor, muscarinic 3 TERCONAZOLE Muscarinic M3 68% 14.537uM 3.081uM View
5-hydroxytryptamine (serotonin) receptor 1B DAUNORUBICIN Serotonin 5-HT1B 68% NoneNone NoneNone View
aldo-keto reductase family 1, member B4 (aldose reductase) FLUVASTATIN Aldose Reductase 68% NoneNone NoneNone View
aldo-keto reductase family 1, member B1 (aldose reductase) FLUVASTATIN Aldose Reductase 68% NoneNone NoneNone View
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) FLUVASTATIN Aldose Reductase 68% NoneNone NoneNone View
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) FLUVASTATIN Aldose Reductase 68% NoneNone NoneNone View
nuclear receptor subfamily 3, group C, member 1 ETHYNODIOL DIACETATE Glucocorticoid 68% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 PIPAMAZINE Dopamine Transporter 68% NoneNone NoneNone View
Cytochrom P450-1A2 monooxygenase MICONAZOLE CYP450-1A2 Inhibition 68% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit OXICONAZOLE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit OXICONAZOLE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit OXICONAZOLE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit OXICONAZOLE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit OXICONAZOLE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit OXICONAZOLE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit OXICONAZOLE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit OXICONAZOLE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit OXICONAZOLE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
nuclear receptor subfamily 3, group C, member 1 CORTISONE Glucocorticoid 72% 2.378uM 1.081uM View
adrenergic receptor, alpha 1a BUSPIRONE Adrenergic alpha1A 72% 3.482uM 1.41uM View
cytochrome P450, family 3, subfamily a, polypeptide 13 DOCETAXEL CYP450-3A4 Inhibition 72% 2uM NoneNone View
adrenergic receptor, beta 3 DIHYDROERGOCRISTINE MESYLATE Adrenergic beta3 72% 3.308uM 2.481uM View
cholinergic receptor, muscarinic 2 QUETIAPINE Muscarinic M2 72% 3.3447uM 1.1892uM View
calcium channel, voltage-dependent, beta 2 subunit RALOXIFENE Calcium Channel Type L, Dihydropyridine 71% .388uM .249uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit RALOXIFENE Calcium Channel Type L, Dihydropyridine 71% .388uM .249uM View
calcium channel, voltage-dependent, alpha 1F subunit RALOXIFENE Calcium Channel Type L, Dihydropyridine 71% .388uM .249uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit RALOXIFENE Calcium Channel Type L, Dihydropyridine 71% .388uM .249uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit RALOXIFENE Calcium Channel Type L, Dihydropyridine 71% .388uM .249uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit RALOXIFENE Calcium Channel Type L, Dihydropyridine 71% .388uM .249uM View
calcium channel, voltage-dependent, beta 1 subunit RALOXIFENE Calcium Channel Type L, Dihydropyridine 71% .388uM .249uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit RALOXIFENE Calcium Channel Type L, Dihydropyridine 71% .388uM .249uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit RALOXIFENE Calcium Channel Type L, Dihydropyridine 71% .388uM .249uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 RALOXIFENE Calcium Channel Type L, Dihydropyridine 71% .388uM .249uM View
calcium channel, voltage-dependent, gamma subunit 8 RALOXIFENE Calcium Channel Type L, Dihydropyridine 71% .388uM .249uM View
calcium channel, voltage-dependent, gamma subunit 7 RALOXIFENE Calcium Channel Type L, Dihydropyridine 71% .388uM .249uM View
calcium channel, voltage-dependent, gamma subunit 6 RALOXIFENE Calcium Channel Type L, Dihydropyridine 71% .388uM .249uM View
Cytochrom P450-2D6 monooxygenase SB-203580 CYP450-2D6 Inhibition 71% 2uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 2C PROPOFOL Serotonin 5-HT2C 71% 11.553uM 6.051uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 DOXAZOSIN Serotonin Transporter 71% 2.688uM 1.428uM View
5-hydroxytryptamine (serotonin) receptor 2C TRIOXSALEN Serotonin 5-HT2C 71% 2.356uM 1.234uM View
opioid receptor, sigma 1 S-(-)-PROPRANOLOL Sigma1 71% 6.665uM 2.801uM View
histamine receptor H 2 LOPERAMIDE Histamine H2 71% 3.081uM 3.03uM View
5-hydroxytryptamine (serotonin) receptor 2B LOPERAMIDE Serotonin 5-HT2B 71% 4.105uM 2.613uM View
prostaglandin-endoperoxide synthase 1 ETODOLAC Cyclooxygenase COX-1 71% 2.649uM NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) ETODOLAC Cyclooxygenase COX-1 71% 2.649uM NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 MITOXANTRONE Adrenergic, Norepinephrine Transporter 71% 4.9898uM 4.9485uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 TROPISETRON GABAA, Agonist Site 71% 3.025uM 2.395uM View
gamma-aminobutyric acid A receptor, gamma 1 TROPISETRON GABAA, Agonist Site 71% 3.025uM 2.395uM View
gamma-aminobutyric acid A receptor, pi TROPISETRON GABAA, Agonist Site 71% 3.025uM 2.395uM View
AT hook, DNA binding motif, containing 1 (DBSS) TROPISETRON GABAA, Agonist Site 71% 3.025uM 2.395uM View
gamma-aminobutyric acid A receptor, theta TROPISETRON GABAA, Agonist Site 71% 3.025uM 2.395uM View
gamma-aminobutyric acid A receptor, gamma 2 TROPISETRON GABAA, Agonist Site 71% 3.025uM 2.395uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 TROPISETRON GABAA, Agonist Site 71% 3.025uM 2.395uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 TROPISETRON GABAA, Agonist Site 71% 3.025uM 2.395uM View
gamma-aminobutyric acid A receptor, alpha 2 TROPISETRON GABAA, Agonist Site 71% 3.025uM 2.395uM View
gamma-aminobutyric acid A receptor, alpha 1 TROPISETRON GABAA, Agonist Site 71% 3.025uM 2.395uM View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 TROPISETRON GABAA, Agonist Site 71% 3.025uM 2.395uM View